Theravance Biopharma, Inc.
USD17.06
-0.57 (-3.23%)
CEO
Rick E. Winningham
IPO Date
2014-05-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.97
Prev. Close
$17.63
Day Low
$16.97
Day High
$17.16
52W Low
$10.82
52W High
$21.03
Market Cap
$0.88B
Volume
3.10M
| -8.1 |
| 31 Dec 2023 | FY | 29.3% | -96.1% | -25.9% | -14.4% | 0.23 | 5.39 | -11.3 |
| 31 Dec 2022 | FY | -23.5% | 1698.5% | 197.4% | 143.6% | 0.12 | 12.31 | 0.9 |
| 31 Dec 2021 | FY | -250.1% | -360.6% | 58.9% | -53.2% | -1.98 | 4.26 | -3.8 |
| 31 Dec 2020 | FY | 100.0% | -386.9% | 91.5% | -59.3% | -2.23 | 3.18 | -4.0 |
| 31 Dec 2019 | FY | 100.0% | -322.1% | 105.6% | -57.8% | -2.28 | 3.03 | -6.1 |
| 31 Dec 2018 | FY | 98.8% | -357.0% | 417.8% | -38.5% | -8.81 | 5.41 | -6.4 |
| 31 Dec 2017 | FY | 60.8% | -1855.0% | -247.8% | -64.7% | 1.94 | 6.05 | -5.1 |
| 31 Dec 2016 | FY | 94.1% | -391.9% | -54.4% | -29.8% | 0.64 | 10.73 | -7.5 |
| 3.9 |
| 30 Sept 2025 | Q3 | 59.4% | 18.1% | 1.6% | 0.9% | 0.19 | 9.48 | 51.0 |
| 30 Jun 2025 | Q2 | 60.0% | 209.3% | 24.4% | 12.9% | 0.21 | 6.70 | 2.5 |
| 31 Mar 2025 | Q1 | 25.6% | -88.2% | -8.2% | -4.0% | 0.29 | 4.77 | -8.2 |
| 31 Dec 2024 | Q4 | 100.0% | -82.8% | -8.8% | -4.4% | 0.28 | 5.02 | -7.5 |
| 30 Sept 2024 | Q3 | 45.1% | -75.3% | -6.8% | -3.6% | 0.24 | 4.97 | -7.8 |
| 30 Jun 2024 | Q2 | 30.2% | -115.9% | -8.5% | -4.6% | 0.24 | 5.20 | -6.3 |
| 31 Mar 2024 | Q1 | 38.2% | -80.4% | -5.7% | -3.1% | 0.23 | 5.74 | -9.3 |
| 31 Dec 2023 | Q4 | 52.7% | -48.4% | -4.0% | -2.2% | 0.23 | 5.39 | -16.3 |